Journal article
CD8 T-cell response to respiratory syncytial virus infection
Future virology, Vol.10(6), pp.779-794
06/01/2015
DOI: 10.2217/fvl.15.43
Abstract
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection and hospitalization among infants. Despite the significant healthcare burden, there is no licensed RSV vaccine currently available. This problem is further exacerbated as a natural RSV infection fails to elicit the development of long-lived immunity. It is well established that RSV-specific antibodies play a critical role in mediating protection from severe disease. The CD8 T-cell response is critical for mediating virus clearance following an acute RSV infection. However, the relative contribution of memory CD8 T cells in providing protection against secondary RSV infections remains unclear. In addition, data from animal models indicate that memory CD8 T-cell responses can be pathogenic under certain conditions. Herein, we provide an overview of the CD8 T-cell response elicited by RSV infection and how our current knowledge may impact future studies and vaccine development.
Details
- Title: Subtitle
- CD8 T-cell response to respiratory syncytial virus infection
- Creators
- Cory J KnudsonSteven M Varga
- Resource Type
- Journal article
- Publication Details
- Future virology, Vol.10(6), pp.779-794
- Publisher
- Future Medicine Ltd
- DOI
- 10.2217/fvl.15.43
- ISSN
- 1746-0794
- eISSN
- 1746-0808
- Language
- English
- Date published
- 06/01/2015
- Academic Unit
- Microbiology and Immunology; Pathology; Graduate College Admin and Gen
- Record Identifier
- 9984083247202771
Metrics
15 Record Views